Added to YB: 2019-09-20
Pitch date: 2019-09-20
ABBV:US [bullish]
AbbVie Inc.
+389.64%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
Market Cap
$443.4B
Pitch Price
$54.32
Price Target
N/A
Dividend
2.76%
EV/EBITDA
16.25
P/E
70.89
EV/Sales
7.87
Sector
Biotechnology
Category
N/A
Show full summary:
AbbVie, Inc. ABBV:US
A summary for this pitch has not been created yet.
Read full article (0 min)